ALEXANDRA SANROMA: Open Payments
NPI 1497128722 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,545 in 121 payments from 14 companies in 2025. Trend: 2023 $1,963 · 2024 $2,532 · 2025 $2,545
Food & beverage: $2,447Education: $98
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 12 | $373 |
| Amgen Inc. | 7 | $319 |
| Novartis Pharmaceuticals Corporation | 17 | $287 |
| ABBVIE INC. | 11 | $210 |
| Lilly USA, LLC | 10 | $209 |
| UCB, Inc. | 11 | $201 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $190 |
| LEO Pharma Inc. | 7 | $187 |
| Galderma Laboratories, L.P. | 8 | $174 |
| Janssen Biotech, Inc. | 17 | $155 |
Products named: DUPIXENT, OTEZLA, COSENTYX, Bimzelx, TALTZ, NEMLUVIO, SKYRIZI, TREMFYA.
Industry payments across AR — which companies pay providers there.
